In vitro methods for antifungal susceptibility testing of Trichophyton spp

Maria Elisabete da Silva Barros1, Daniel de Assis Santos, Júnia Soares Hamdan

  • 1Department of Microbiology, Institute of Biological Sciences, Federal University of Minas Gerais, Av. Antônio Carlos, 6627 PO Box 486 CEP: 31.270-901, Belo Horizonte, Minas Gerais, Brazil. betebarros@ef.ufop.br

Mycological Research
|October 31, 2006
PubMed

Insights

Standardized antifungal susceptibility testing for dermatophytes is lacking. Modified CLSI and EUCAST methods using specific media, temperature, and incubation periods show promising, reproducible results for dermatophyte drug resistance.

Area of Science:

  • Mycology
  • Antimicrobial Resistance
  • Clinical Laboratory Science

Background:

  • Standardized methods for antifungal susceptibility testing are crucial but lacking for dermatophytes.
  • Existing protocols (CLSI M38-A, EUCAST) are designed for moulds and yeasts, not optimally suited for dermatophyte growth characteristics.

Purpose of the Study:

  • To adapt and evaluate modified CLSI and EUCAST protocols for reliable antifungal susceptibility testing of dermatophytes.
  • To establish optimized conditions for dermatophyte growth and sporulation to improve testing accuracy.

Main Methods:

  • Modified potato dextrose agar with rice flour and RPMI-1640 with glucose were used.
  • Incubation at 28°C for 7 days with microconidia inocula and 80% growth inhibition for MIC determination were employed.

Main Results:

  • Modified protocols yielded highly reproducible results comparable to existing research.
  • MIC90 values were identical for four of five antifungal drugs tested; MIC50 values showed minimal variation (one to two dilutions).

Conclusions:

  • The introduced modifications provide a reliable basis for dermatophyte antifungal susceptibility testing.
  • Further studies are needed to establish a universally accepted standard technique for dermatophyte antifungal drug susceptibility.

Related Concept Videos